Antiviral activity against influenza A virus (A/Krasnodar/101/1959(H2N2)) infected in hen chorioallantoic membrane assessed as inhibition of viral infectivity after 48 hrs
Antiviral activity against Influenza A virus (A/Japan/305/57(H2N2)) infected BALB/c mouse assessed as mouse survival at 20 mg/kg, ip administered once daily from day 4 to 10 post viral challenge
Antiviral activity against Influenza A virus (A/Japan/305/57(H2N2)) infected BALB/c mouse assessed as mouse survival at 40 mg/kg, ip administered once daily from day 4 to 10 post viral challenge
Antiviral activity against Influenza A virus (A/Japan/305/57(H2N2)) infected BALB/c mouse assessed as mouse survival at 60 mg/kg, ip administered once daily from day 4 to 10 post viral challenge
Antiviral activity against Influenza A virus (A/Japan/305/57(H2N2)) infected BALB/c mouse assessed as infection-induced weight loss at 20 mg/kg, ip administered once daily from day 4 to 10 post viral challenge measured on day 4 postinfection
Antiviral activity against Influenza A virus (A/Japan/305/57(H2N2)) infected BALB/c mouse assessed as infection-induced weight loss at 40 mg/kg, ip administered once daily from day 4 to 10 post viral challenge measured on day 4 postinfection
Antiviral activity against Influenza A virus (A/Japan/305/57(H2N2)) infected BALB/c mouse assessed as infection-induced weight loss at 60 mg/kg, ip administered once daily from day 4 to 10 post viral challenge measured on day 4 postinfection
Antiviral activity against Influenza A virus (A/Japan/305/57(H2N2)) infected BALB/c mouse assessed as infection-induced weight loss at 20 mg/kg, ip administered once daily from day 4 to 10 post viral challenge measured on day 6 postinfection
Antiviral activity against Influenza A virus (A/Japan/305/57(H2N2)) infected BALB/c mouse assessed as infection-induced weight loss at 40 mg/kg, ip administered once daily from day 4 to 10 post viral challenge measured on day 6 postinfection
Antiviral activity against Influenza A virus (A/Japan/305/57(H2N2)) infected BALB/c mouse assessed as infection-induced weight loss at 60 mg/kg, ip administered once daily from day 4 to 10 post viral challenge measured on day 6 postinfection
Antiviral activity against Influenza A virus (A/Japan/305/57(H2N2)) infected BALB/c mouse assessed as infection-induced weight loss at 20 mg/kg, ip administered once daily from day 4 to 10 post viral challenge measured on day 8 postinfection
Antiviral activity against Influenza A virus (A/Japan/305/57(H2N2)) infected BALB/c mouse assessed as infection-induced weight loss at 40 mg/kg, ip administered once daily from day 4 to 10 post viral challenge measured on day 8 postinfection
Antiviral activity against Influenza A virus (A/Japan/305/57(H2N2)) infected BALB/c mouse assessed as infection-induced weight loss at 60 mg/kg, ip administered once daily from day 4 to 10 post viral challenge measured on day 8 postinfection
Antiviral activity against Influenza A virus (A/Japan/305/57(H2N2)) infected BALB/c mouse assessed as infection-induced weight loss at 20 mg/kg, ip administered once daily from day 4 to 10 post viral challenge measured on day 10 postinfection
Antiviral activity against Influenza A virus (A/Japan/305/57(H2N2)) infected BALB/c mouse assessed as infection-induced weight loss at 40 mg/kg, ip administered once daily from day 4 to 10 post viral challenge measured on day 10 postinfection
Antiviral activity against Influenza A virus (A/Japan/305/57(H2N2)) infected BALB/c mouse assessed as infection-induced weight loss at 60 mg/kg, ip administered once daily from day 4 to 10 post viral challenge measured on day 10 postinfection
Antiviral activity against Influenza A virus (A/Japan/305/57(H2N2)) infected BALB/c mouse assessed as infection-induced weight loss at 20 mg/kg, ip administered once daily from day 4 to 10 post viral challenge measured on day 12 postinfection
Antiviral activity against Influenza A virus (A/Japan/305/57(H2N2)) infected BALB/c mouse assessed as infection-induced weight loss at 40 mg/kg, ip administered once daily from day 4 to 10 post viral challenge measured on day 12 postinfection
Antiviral activity against Influenza A virus (A/Japan/305/57(H2N2)) infected BALB/c mouse assessed as infection-induced weight loss at 60 mg/kg, ip administered once daily from day 4 to 10 post viral challenge measured on day 12 postinfection